New vaccines for a safer world

The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership launched  in 2017 to develop vaccines to stop future epidemics.

COVAX: CEPI's response to COVID-19

CEPI, Gavi and the WHO have launched COVAX to ensure equitable access to COVID-19 vaccines and end the acute phase of the pandemic by the end of 2021.

We want to create a world in which epidemics are no longer a threat to humanity.

CEPI wants to galvanise the development of new vaccines against diseases we know could cause the next devastating epidemic.

Our approach

$570bn

The estimated annual global cost of moderately severe to severe pandemics

Eleven

The number of diseases WHO identified as public health risks due to epidemic potential and lack of biomedical countermeasures

$2.8bn

The minimum average cost for progressing one vaccine against each of WHO’s 11 priority epidemic infectious diseases

Epidemic diseases affect us all. They do not respect borders.

CEPI (pronounced 'seppy') aims to accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks.

Ahmedabad, India (Paula Bronstein/Getty Images Reportage)